APA (7th ed.) Citation

Seo, Y., Park, Y. H., Ahn, J. S., Im, Y., Nam, S. J., Cho, S. Y., & Cho, E. Y. (2018). PIK3CA Mutations and Neoadjuvant Therapy Outcome in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Sequential Analysis. Journal of breast cancer, 21(4), 382-390. https://doi.org/10.4048/jbc.2018.21.e48

Chicago Style (17th ed.) Citation

Seo, Youjeong, Yeon Hee Park, Jin Seok Ahn, Young-Hyuck Im, Seok Jin Nam, Soo Youn Cho, and Eun Yoon Cho. "PIK3CA Mutations and Neoadjuvant Therapy Outcome in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Sequential Analysis." Journal of Breast Cancer 21, no. 4 (2018): 382-390. https://doi.org/10.4048/jbc.2018.21.e48.

MLA (9th ed.) Citation

Seo, Youjeong, et al. "PIK3CA Mutations and Neoadjuvant Therapy Outcome in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Sequential Analysis." Journal of Breast Cancer, vol. 21, no. 4, 2018, pp. 382-390, https://doi.org/10.4048/jbc.2018.21.e48.